Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2021-06-19 Regulatory Filings
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the recording of a virtual meeting with media, specifically an interview of the CEO discussing financial results and business outlook. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document provides links to the interview recording but does not contain actual financial data or detailed financial statements. The length is short (1189 characters), and it is an announcement of a media interaction rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), as it is a general regulatory announcement and does not fit into more specific categories like Call Transcript or Earnings Release.
2021-06-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 60% confidence The document is very short (402 characters) and appears to be a brief schedule or note about a meeting involving discussion on financial results and business outlook with a CEO. There is no detailed financial data, no formal report, and no indication of a full transcript or presentation. It resembles a meeting note or announcement rather than a full report or transcript. Given the mention of discussion on financial results and business outlook in a meeting context, the closest fitting category is 'Investor Presentation' (IP), as it involves financial and strategic discussion typically presented to investors. However, since the document is extremely brief and does not contain actual presentation content, it might also be considered a Regulatory Filing (RNS) as a fallback. But the mention of 'Discussion on Financial Results and Business Outlook' and 'virtual meet' suggests it is related to an investor presentation or meeting. Therefore, the best classification is Investor Presentation (IP) with moderate confidence due to brevity.
2021-06-18 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings
2021-06-17 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of financial results for the quarter and financial year ended March 31, 2021. It mentions furnishing a newspaper copy of the financial results published in newspapers. The document is a notification or announcement about the publication of financial results rather than the financial results report itself. It does not contain detailed financial statements or substantive financial data but serves to inform the exchanges and public about the publication of the results. Therefore, it fits the category of Regulatory Filings (RNS), which is used for general regulatory announcements and miscellaneous filings that do not fit other categories.
2021-06-17 English
Change in Director(s)
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors meeting dated June 16, 2021. It includes the appointment of new directors and a CFO, which is typical of Board/Management Information filings. It also contains audited financial results for the quarter and year ended March 31, 2021, including standalone and consolidated results, auditor's reports, statement of assets and liabilities, cash flow statement, and a certificate for unmodified opinion. The document also mentions a recommended final dividend subject to approval at the AGM. The presence of comprehensive financial statements and audit reports within the document indicates it is not merely an announcement but contains substantive financial data. Therefore, the document fits the definition of an Interim / Quarterly Report (IR) because it covers quarterly and annual financial results with detailed financial data and analysis, not just a brief earnings release or announcement. It is not a full Annual Report (10-K) as it focuses on quarterly and year-end results without the broader annual report content. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains full financial data, not just a notice or certification. Hence, the best classification is Interim / Quarterly Report (IR). FY 2021
2021-06-16 English
Appointment
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors meeting dated June 16, 2021. It includes the appointment of new directors and a CFO, which is typical of Board/Management Information filings. It also contains audited financial results for the quarter and year ended March 31, 2021, including standalone and consolidated results, auditor's reports, statement of assets and liabilities, cash flow statement, and a certificate for unmodified opinion. The document also mentions a recommended final dividend subject to approval at the AGM. The presence of comprehensive financial statements and audit reports within the document indicates it is not merely an announcement or a brief summary but a full financial report. The detailed financial data and audit information align with the characteristics of an Annual Report (10-K equivalent) rather than a short earnings release or a regulatory filing. Therefore, the document should be classified as an Annual Report (10-K). FY 2021
2021-06-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.